BANK OF MONTREAL /CAN/ - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$1,952,851
-67.8%
123,520
-61.6%
0.00%
-50.0%
Q2 2023$6,073,601
+1219.6%
321,695
+250.2%
0.00%
Q4 2022$460,265
+461.3%
91,869
+483.0%
0.00%
Q3 2022$82,000
+74.5%
15,759
+43.4%
0.00%
Q2 2022$47,000
-99.0%
10,990
-98.3%
0.00%
-100.0%
Q4 2021$4,876,000
+9100.0%
652,756
+9526.2%
0.00%
Q1 2021$53,000
-73.8%
6,781
-76.9%
0.00%
Q4 2020$202,000
+445.9%
29,360
+240.8%
0.00%
Q3 2020$37,000
-46.4%
8,616
-40.3%
0.00%
Q2 2020$69,000
+3350.0%
14,421
+2075.1%
0.00%
Q1 2020$2,000
-97.9%
663
-96.5%
0.00%
Q4 2019$97,000
+193.9%
18,959
+41.6%
0.00%
Q3 2019$33,000
+22.2%
13,388
+4.5%
0.00%
Q2 2019$27,000
+1250.0%
12,816
+1702.5%
0.00%
Q1 2019$2,000
-84.6%
711
-73.7%
0.00%
Q4 2018$13,000
-13.3%
2,700
+63.2%
0.00%
Q3 2018$15,000
-98.4%
1,654
-98.3%
0.00%
-100.0%
Q2 2018$935,000
+13257.1%
96,076
+14391.1%
0.00%
Q1 2018$7,000
-12.5%
663
-50.1%
0.00%
Q4 2017$8,000
-55.6%
1,328
-43.3%
0.00%
Q3 2017$18,000
+80.0%
2,344
+76.5%
0.00%
Q2 2017$10,000
+66.7%
1,328
-4.7%
0.00%
Q1 2017$6,000
+200.0%
1,394
+5.0%
0.00%
Q4 2016$2,0000.0%1,328
+99.7%
0.00%
Q3 2016$2,000
-93.8%
665
-93.8%
0.00%
Q2 2016$32,000
-20.0%
10,665
+125.5%
0.00%
Q1 2016$40,000
-27.3%
4,730
+16.4%
0.00%
Q4 2015$55,000
+41.0%
4,0650.0%0.00%
Q3 2015$39,000
-15.2%
4,065
+27.0%
0.00%
Q2 2015$46,000
+58.6%
3,2000.0%0.00%
Q1 2015$29,000
+45.0%
3,2000.0%0.00%
Q4 2014$20,000
-41.2%
3,2000.0%0.00%
Q3 2014$34,000
-46.0%
3,200
-39.6%
0.00%
Q2 2014$63,000
+31.2%
5,300
+65.6%
0.00%
Q1 2014$48,000
+2.1%
3,2000.0%0.00%
Q4 2013$47,000
-14.5%
3,200
-1.1%
0.00%
Q3 2013$55,000
+3.8%
3,236
+1.1%
0.00%
Q2 2013$53,0003,2000.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders